CN102579753A - Chinese medicinal composition for treating deficiency of qi and the blood after mammary cancer surgery - Google Patents

Chinese medicinal composition for treating deficiency of qi and the blood after mammary cancer surgery Download PDF

Info

Publication number
CN102579753A
CN102579753A CN2011100076420A CN201110007642A CN102579753A CN 102579753 A CN102579753 A CN 102579753A CN 2011100076420 A CN2011100076420 A CN 2011100076420A CN 201110007642 A CN201110007642 A CN 201110007642A CN 102579753 A CN102579753 A CN 102579753A
Authority
CN
China
Prior art keywords
blood
chinese medicine
radix
chinese
breast carcinoma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2011100076420A
Other languages
Chinese (zh)
Inventor
娄怡
丁园园
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tianjin Zhongbao Pharmaceutical Co Ltd
Original Assignee
Tianjin Zhongbao Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tianjin Zhongbao Pharmaceutical Co Ltd filed Critical Tianjin Zhongbao Pharmaceutical Co Ltd
Priority to CN2011100076420A priority Critical patent/CN102579753A/en
Publication of CN102579753A publication Critical patent/CN102579753A/en
Pending legal-status Critical Current

Links

Abstract

The invention belongs to the field of Chinese medicines, in particular to a Chinese medicinal composition for treating deficiency of qi and the blood after mammary cancer surgery. The Chinese medicinal composition mainly comprises the following Chinese medicinal components by weight: 20-30g of astragalus, 9-15g of Chinese angelica, 9-15g of prepared rehmannia rhizome, 9-15g of south dodder seed, 9-15g of desertliving cistanche, 9-15g of Chinese yam, 15-20g of indian buead, 15-20g of dried large-head atractylodes rhizome, 6-10g of Chinese thorowax root, 6-10g of dried orange peel and 3-6g of liquoric root. The Chinese medicinal composition has the effects of replenishing qi to invigorate the spleen, warming the yang and tonifying the kidney, and has a definite curative effect on a patient suffering from deficiency of qi and the blood after mammary cancer surgery.

Description

A kind of Chinese medicine composition of treating breast carcinoma postoperative deficient qi and blood
Technical field
The invention belongs to the field of Chinese medicines.
Background technology
Breast carcinoma is a malignant tumor among the whole world women, and have 7.9 ten thousand new cases every year approximately, accounts for whole women's malignant tumor sums 21%.Its morbidity is normal relevant with heredity, and between 40-60 year, menopause front and back women's sickness rate higher.Only the mammary gland patient of about 1-2% is the male.Usually occur in the malignant tumor of breast glandular epithelium tissue.Be one of a kind of women's of having a strong impact on physical and mental health even life-threatening modal malignant tumor, male breast carcinoma is rare.Doctor trained in Western medicine thinks that the generation of breast carcinoma is relevant with following high risk factor: sterile, the fertility number of times is few, first tire term birth evening at age, age of menarche morning, optimum mastopathy history, family history of breast cancer, oral contraceptive, radiation exposure, bad life habits, environmental pollution, viral infection etc.The traditional Chinese medical science thinks that vital QI being weakened and pathogen being violent is total pathogenesis of breast carcinoma morbidity.Positive QI-insufficiency is the main cause that breast carcinoma takes place, and the pathogen invasion then is an essential condition.Healthy energy is deficient, and internal organs are become estranged, imbalance of YIN and YANG, and the heresy of six climate exopathogens is being taken advantage of a weak point in opponent's defence in newborn portion, and meridians are obstructed, and become to the tumor karyomorphism.
Breast carcinoma at present treatment is main with operation, cooperate put, Comprehensive Treatment such as chemotherapy, but put, toxicity that chemotherapy is brought is also very obvious.Chinese medicine breast carcinoma has long history; The Chinese medicine primary disease; Mainly be to carry out further conditioning and treating, not only can disease controlling develop, and can improve recent symptom at the mammary cancer surgery postoperative; To consolidating the state of an illness bigger help is arranged, strengthening the body resistance, eliminating evil, transfer body resistance against diseases, alleviate and effect of crucial importance and unique advantage are arranged aspect the side effect of other treatment.
Summary of the invention
The present invention aims to provide a kind of Chinese medicine composition of treating breast carcinoma postoperative deficient qi and blood, so that provide more medications to select for clinical.
A kind of Chinese medicine composition of treating breast carcinoma postoperative deficient qi and blood; Mainly comprise following traditional Chinese medicine components by weight ratio: the Radix Astragali 20~30g, Radix Angelicae Sinensis, Radix Rehmanniae Preparata, Semen Cuscutae, Herba Cistanches, each 9~15g of Rhizoma Dioscoreae, Poria, each 15~20g of the Rhizoma Atractylodis Macrocephalae; Radix Bupleuri, each 6~10g of Pericarpium Citri Reticulatae, Radix Glycyrrhizae 3~6g.
The women of breast carcinoma postoperative because of major operation consumption impairment of QI blood, has more the performance that the positive at present deficiency of vital energy declines, and reuses Radix Astragali harmonizing the spleen and stomach in the side, and the QI invigorating poison holding not only can the enhancing human body immunity function, and can anticancerly press down cancer.Rhizoma Atractylodis Macrocephalae invigorating the spleen and benefiting QI is spleen QI invigorating first key medicine; Rhizoma Dioscoreae spleen reinforcing nourishing the stomach, the lung benefiting the kidney invigorating of promoting the production of body fluid; Poria eliminating dampness by diuresis, spleen invigorating, mind calming; The Pericarpium Citri Reticulatae regulating qi-flowing for strengthening spleen; The Rhizoma Atractylodis Macrocephalae, Rhizoma Dioscoreae, Poria, Pericarpium Citri Reticulatae etc. help Radix Astragali replenishing QI to invigorate the spleen activating the spleen, help QI and blood, turn round and look to protect the day after tomorrow, make QI and blood biochemistry active, and the vital organs of the human body all receive it.The Chinese angelica blood supplementing regulating menstruation, promoting blood circulation and stopping pain; Radix Rehmanniae Preparata nourishes blood and enriches blood, life essence-filling, marrow-benefitting; Be the key medicine of enriching blood that nourishes blood.The Radix Bupleuri dispersing the stagnated live-QI to relieve the stagnation of QI is given birth to and is lifted yang-energy; The old regulating qi-flowing for strengthening spleen of Pericarpium Citri Reticulatae; Radix Bupleuri, the orderly and clearly mechanism of qi of Pericarpium Citri Reticulatae cooperate nourishing blood to suppress the hyperactive liver with the Radix Paeoniae Alba.Semen Cuscutae, Herba Cistanches, Rhizoma Dioscoreae invigorating kidney qi, regulating thoroughfare and controlling vessel, astringency inducing is congenital, makes and is able to balance the congenital day after tomorrow, and healthy energy is full, gets rid of evils and goes out, and prevents or delays the cancerous protuberance relapse and metastasis.The Radix Glycyrrhizae coordinating the actions of various ingredients in a prescription.
The traditional Chinese medical science had both been considered partial treatment owing to from organic conception, implement determination of treatment based on pathogenesis obtained through differentiation of symptoms and signs, taked the method for the body resistance strengthening and constitution consolidating again, all had important effect for the local symptom of improving the patient and overall health of patients.Operation no doubt can be excised cancerous protuberance, but also has in residual cancer or regional lymph node metastasis or the blood vessel cancer embolus existence etc., and the long-term treatment of utilization Chinese medicine postoperative can prevent recurrence and shifts, and can remedy operative treatment, radiotherapy, chemotherapeutical deficiency.Radiotherapy, chemotherapeutic treatment have certain side effect to body, the utilization traditional Chinese medical herbal treatment can alleviate put, the side effect of chemotherapy, can strengthen the effect of radiotherapy, chemotherapy again.
The present invention has replenishing QI to invigorate the spleen, and the merit of temperature male wind-supplying kidney has definite curative effect for the sufferer of breast carcinoma postoperative deficient qi and blood.For the advanced breast cancer patient maybe can not operation and the sufferer of radiotherapy, chemotherapy can adopt traditional Chinese medical herbal treatment, prolong patient's life, improve the quality of living.
The specific embodiment
Example 1
The Radix Astragali 20~30g, Radix Angelicae Sinensis, Radix Rehmanniae Preparata, Semen Cuscutae, Herba Cistanches, each 9~15g of Rhizoma Dioscoreae, Poria, each 15~20g of the Rhizoma Atractylodis Macrocephalae, Radix Bupleuri, each 6~10g of Pericarpium Citri Reticulatae, Radix Glycyrrhizae 3~6g.Two doses of every days, decocting extracting juice clothes are used to treat breast carcinoma postoperative deficient qi and blood sufferer, 15 days courses of treatment.
Example 2
The Radix Astragali 20~30g, Radix Angelicae Sinensis, Radix Rehmanniae Preparata, Semen Cuscutae, Herba Cistanches, each 9~15g of Rhizoma Dioscoreae, Poria, each 15~20g of the Rhizoma Atractylodis Macrocephalae, Radix Bupleuri, each 6~10g of Pericarpium Citri Reticulatae, Radix Glycyrrhizae 3~6g.The insomniac adds Fructus Schisandrae Chinensis, Radix Polygalae, each 6~9g of Semen Ziziphi Spinosae, and two doses of every days, decocting extracting juice clothes are used to treat breast carcinoma postoperative deficient qi and blood sufferer, 15 days courses of treatment.
Example 3
The Radix Astragali 20~30g, Radix Angelicae Sinensis, Radix Rehmanniae Preparata, Semen Cuscutae, Herba Cistanches, each 9~15g of Rhizoma Dioscoreae, Poria, each 15~20g of the Rhizoma Atractylodis Macrocephalae, Radix Bupleuri, each 6~10g of Pericarpium Citri Reticulatae, Radix Glycyrrhizae 3~6g.Breast side of body breast feeling of distension and oppression pain adds Rhizoma Cyperi, Radix Curcumae, Rhizoma Corydalis, each 9~15g of Rhizoma Chuanxiong, evacuates to transfer to reach, and circulation of qi promoting relieves the pain.Two doses of every days, decocting extracting juice clothes are used to treat breast carcinoma postoperative deficient qi and blood sufferer, 15 days courses of treatment.
Example 4
The Radix Astragali 20~30g, Radix Angelicae Sinensis, Radix Rehmanniae Preparata, Semen Cuscutae, Herba Cistanches, each 9~15g of Rhizoma Dioscoreae, Poria, each 15~20g of the Rhizoma Atractylodis Macrocephalae, Radix Bupleuri, each 6~10g of Pericarpium Citri Reticulatae, Radix Glycyrrhizae 3~6g.The loose stool is more than, watery stool adds Fructus Schisandrae Chinensis 6~9g, astringent therapy antidiarrheal.Two doses of every days, decocting extracting juice clothes are used to treat breast carcinoma postoperative deficient qi and blood sufferer, 15 days courses of treatment.
Treat breast carcinoma postoperative deficient qi and blood sufferer 22 examples with the present invention.Maximum 66 years old minimum 40 years old average 55.5 years old; With 15 days be a course of treatment, after three courses of treatment, therapeutic outcome: (patient is conscious energetic to cure 6 examples; Activity can necessarily expend bodily strength); Effective 15 examples (the conscious spirit of patient still can weak sx, can carry out general activity), total effective rate 95.45%.Invalid 1 example.Do not see that toxic and side effects takes place.

Claims (4)

1. Chinese medicine composition of treating breast carcinoma postoperative deficient qi and blood; It is characterized in that mainly comprising following traditional Chinese medicine components by weight ratio: the Radix Astragali 20~30g; Radix Angelicae Sinensis, Radix Rehmanniae Preparata, Semen Cuscutae, Herba Cistanches, each 9~15g of Rhizoma Dioscoreae; Poria, each 15~20g of the Rhizoma Atractylodis Macrocephalae, Radix Bupleuri, each 6~10g of Pericarpium Citri Reticulatae, Radix Glycyrrhizae 3~6g.
2. the Chinese medicine composition of treatment breast carcinoma postoperative deficient qi and blood according to claim 1 is characterized in that, also comprises following traditional Chinese medicine components by weight ratio: Fructus Schisandrae Chinensis, Radix Polygalae, each 6~9g of Semen Ziziphi Spinosae.
3. the Chinese medicine composition of treatment breast carcinoma postoperative deficient qi and blood according to claim 1 is characterized in that, also comprises following traditional Chinese medicine components by weight ratio: Rhizoma Cyperi, Radix Curcumae, Rhizoma Corydalis, each 9~15g of Rhizoma Chuanxiong.
4. the Chinese medicine composition of treatment breast carcinoma postoperative deficient qi and blood according to claim 1 is characterized in that, also comprises following traditional Chinese medicine components by weight ratio: Fructus Schisandrae Chinensis 6~9g.
CN2011100076420A 2011-01-14 2011-01-14 Chinese medicinal composition for treating deficiency of qi and the blood after mammary cancer surgery Pending CN102579753A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2011100076420A CN102579753A (en) 2011-01-14 2011-01-14 Chinese medicinal composition for treating deficiency of qi and the blood after mammary cancer surgery

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2011100076420A CN102579753A (en) 2011-01-14 2011-01-14 Chinese medicinal composition for treating deficiency of qi and the blood after mammary cancer surgery

Publications (1)

Publication Number Publication Date
CN102579753A true CN102579753A (en) 2012-07-18

Family

ID=46469355

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2011100076420A Pending CN102579753A (en) 2011-01-14 2011-01-14 Chinese medicinal composition for treating deficiency of qi and the blood after mammary cancer surgery

Country Status (1)

Country Link
CN (1) CN102579753A (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103028090A (en) * 2012-12-23 2013-04-10 丁常燕 Traditional Chinese medicine composition for treating Qi deficiency
CN103417665A (en) * 2013-08-12 2013-12-04 大连大学 Chinese herbal medicine compound preparation with functions of reinforcing qi, nourishing blood, tranquilizing and promoting lactation and preparation method and application of preparation
CN103690924A (en) * 2014-01-06 2014-04-02 河南中医学院 Traditional Chinese medicine for improving postoperative yin-yang deficiency syndrome of thyroid cancer
CN105055850A (en) * 2015-07-30 2015-11-18 庞群 Chinese herbal medicament for treating responses to breast cancer radiotherapy and chemotherapy
CN105362369A (en) * 2015-11-10 2016-03-02 首都医科大学附属北京中医医院 Application of liver soothing and spleen strengthening traditional Chinese medicinal composition in preparing medicine for treating sleep disorder in patients of breast carcinoma
CN109875033A (en) * 2019-01-31 2019-06-14 武汉藻优生物科技有限公司 A kind of vine tea oral solution suitable for women

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103028090A (en) * 2012-12-23 2013-04-10 丁常燕 Traditional Chinese medicine composition for treating Qi deficiency
CN103028090B (en) * 2012-12-23 2014-10-29 王新本 Traditional Chinese medicine composition for treating Qi deficiency
CN103417665A (en) * 2013-08-12 2013-12-04 大连大学 Chinese herbal medicine compound preparation with functions of reinforcing qi, nourishing blood, tranquilizing and promoting lactation and preparation method and application of preparation
CN103417665B (en) * 2013-08-12 2015-04-01 大连大学 Chinese herbal medicine compound preparation with functions of reinforcing qi, nourishing blood, tranquilizing and promoting lactation and preparation method and application of preparation
CN103690924A (en) * 2014-01-06 2014-04-02 河南中医学院 Traditional Chinese medicine for improving postoperative yin-yang deficiency syndrome of thyroid cancer
CN103690924B (en) * 2014-01-06 2015-09-30 河南中医学院 A kind of Chinese medicine improving the postoperative deficiency syndrome of both YIN and YANG of thyroid carcinoma
CN105055850A (en) * 2015-07-30 2015-11-18 庞群 Chinese herbal medicament for treating responses to breast cancer radiotherapy and chemotherapy
CN105362369A (en) * 2015-11-10 2016-03-02 首都医科大学附属北京中医医院 Application of liver soothing and spleen strengthening traditional Chinese medicinal composition in preparing medicine for treating sleep disorder in patients of breast carcinoma
CN109875033A (en) * 2019-01-31 2019-06-14 武汉藻优生物科技有限公司 A kind of vine tea oral solution suitable for women

Similar Documents

Publication Publication Date Title
CN102940721B (en) Medicine for treating chronic pelvic inflammation
CN102512565A (en) Traditional Chinese medicine composition for treating lumbago due to kidney deficiency
CN102872418A (en) Medicine for treating pelvic inflammation
CN103007191A (en) Chinese medicinal composition for treating jaundice
CN102579753A (en) Chinese medicinal composition for treating deficiency of qi and the blood after mammary cancer surgery
CN102697947A (en) Traditional Chinese medicine prescription for treating constipation
CN103316174A (en) Traditional Chinese medicinal composition for treating acute cholecystitis and preparation method thereof
CN104383390A (en) Chinese traditional medicine preparation for treating lung cancer
CN102058784A (en) Medicinal composition for treating pulmonary heart disease and application thereof
CN102600426B (en) Chinese medicinal preparation for promoting blood circulation to remove blood stasis and preparation method thereof
CN103393989A (en) Traditional Chinese medicine composition for treating gynecologic inflammation
CN104721792A (en) Traditional Chinese medicine composition for treating intolerance of cold
CN103721230A (en) Traditional Chinese medicinal composition for treating liver cancer
CN101313952A (en) Traditional Chinese herb medicine for treating cancer
CN103127294A (en) Traditional Chinese medicine composition for treating chronic nephritis
CN101428114B (en) Medicament for treating chronic hepatitis B, cirrhosis and liver ascites
CN102988887A (en) Chinese medicament for treating ovarian cyst
CN102357227A (en) Chinese medicinal composition for treating qi stagnation and blood stasis amenorrhea
CN101422547B (en) Traditional Chinese medicine for treating kidney-deficiency blood-insufficiency type amenorrhea
CN102397438A (en) Medicine for treating low renal function
CN101721669A (en) Traditional Chinese medicine composition for treating cold dampness type sciatica
CN102343009B (en) Traditional Chinese medicine for treating dysmenorrhea
CN101485823B (en) Medicament for treating lung cancer and preparation method thereof
CN101683446A (en) Traditional Chinese medicine composition with function of invigorating circulation and reducing blood fat
CN101091764A (en) Composition of Chinese traditional medicine for treating chronic nephritis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20120718